Symbicort SMART (Symbicort Maintenance And Reliever Therapy) - SMART

Study identifier:NIS-RKR-SYM-2007/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

SMART (Symbicort Maintenance And Reliever Therapy): Reassure program for patients using Symbicort Turbuhaler as maintenance and reliever therapy in Korean clinical practice

Medical condition

asthma

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

2000

Study type

Observational

Age

12 Years +

Date

Study Start Date: 01 Jul 2007

Primary Completion Date: -

Study Completion Date: 01 Jul 2008

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jul 2009 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

http://www.astrazeneca.com/node/emailtriage.aspx
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Korea Clinical Study

0082-2-2188-2145

[email protected]

Investigators

Principal Investigator

Joon-Woo Bahn

AstraZeneca Korea